DVL3 and non-small cell lung carcinoma: DVL3 also affects the malignant phenotype of NSCLC through the non-canonical Wnt-PCP pathway but not the canonical Wnt pathway in NSCLC cells (A549, SPC, H157, H460, and LTE) [36].